What does Vyome Holdings, Inc. do?
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase…
What is Vyome Holdings, Inc.'s P/E and P/B ratio?
Vyome Holdings, Inc. has a P/E ratio of 1.0 and a P/B ratio of 2.09.
What is Vyome Holdings, Inc.'s debt-to-equity ratio?
Vyome Holdings, Inc. has a debt-to-equity ratio of 0.00.
How much does Vyome Holdings, Inc. owe compared with what it owns?
Vyome Holdings, Inc. owes $0.20 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Vyome Holdings, Inc.'s Positivity rank?
Vyome Holdings, Inc. is ranked #65 of 6,774 companies globally and #18 of 4,000 in United States on PositoAI, with a Positivity Score of 25,696.
Does Vyome Holdings, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Vyome Holdings, Inc..
Where can I read the latest news about Vyome Holdings, Inc.?
Recent headlines about Vyome Holdings, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Vyome Holdings, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Vyome Holdings, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.